Insider · CIK 0002009309
Christopher Jon Jones
Files at TRUG (Deep Medicine Acquisition Corp.). First filing -, latest -.
In brief
Christopher Jon Jones files SEC Form 4 as CEO, director and 10% owner at TRUG (Deep Medicine Acquisition Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher Jon Jones has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | TRUG Deep Medicine Acquisition Corp. | AGrant or award Class A Common Stock | +1,812,417 | - | - | 3,744,400 | Apr 25, 2025 |
| Apr 21, 2025 | TRUG Deep Medicine Acquisition Corp. | AGrant or award Class B Common Stock | +4,184,342 | - | - | 5,044,424 | Apr 25, 2025 |
Questions about Christopher Jon Jones
Answered from the filings on this page, as of the latest one.
Is Christopher Jon Jones buying or selling?
Christopher Jon Jones has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher Jon Jones's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher Jon Jones has 0.
Where does Christopher Jon Jones file Form 4?
Christopher Jon Jones has filed Form 4 at TRUG (Deep Medicine Acquisition Corp.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.